Torrent Pharma surged after announcing a ₹25,689 crore deal to acquire a 49.18% stake in JB Pharma, India 2nd-largest pharma acquisition. The analyst sees a breakout above ₹3,361 as bullish, with targets of ₹3,570-3,980. Integration, funding, and regulatory risks remain. Stocktwits sentiment turned bullish for both stocks after the news, though JB Pharma fell 6% on valuation concerns.